ALC.ASX: Q4 FY26 Quarterly Activities Report and Appendix 4C

Q4 FY26 Quarterly Activities Report and Appendix 4C

Stock	Alcidion Group Ltd (ALC.ASX)
Release Time	23 Jul 2026, 8:27 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Alcidion Group Ltd Q4 FY26 Quarterly Activities Report

Key Points

Record Q4 positive operating cashflow of $7.7M
FY26 positive operating cashflow of $6.8M, up 19%
Completed acquisition of Kyra flow products from Telstra Health
Cash balance of $20.6M, no debt as of 30 June 2026
FY26 revenue expected to be ~$51.6M, EBITDA to exceed $5.0M

Full Summary

Alcidion Group Ltd released its Q4 FY26 Quarterly Activities Report, highlighting a record positive operating cashflow of $7.7M for the quarter and $6.8M for the full year, up 19% from FY25. The company also completed the acquisition of Kyra flow products from Telstra Health, adding 31 new customers across ANZ. Alcidion's cash balance stood at $20.6M with no debt as of 30 June 2026. The company reconfirms its FY26 financial guidance with revenue expected to be ~$51.6M and EBITDA to exceed $5.0M. Alcidion enters FY27 with strong momentum and a significant book of implementation revenue.

Guidance

FY26 revenue expected to be ~$51.6M, EBITDA to exceed $5.0M

Outlook

Alcidion enters FY27 with strong momentum across all existing markets and continues to progress several opportunities while maintaining a significant book of implementation revenue.